MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
190 hedge funds and large institutions have $5.5B invested in Mirati Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 69 increasing their positions, 62 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
190
Holders Change
+13
Holders Change %
+7.34%
% of All Funds
3.75%
Holding in Top 10
10
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+66.67%
% of All Funds
0.2%
New
46
Increased
69
Reduced
62
Closed
28
Calls
$232M
Puts
$107M
Net Calls
+$125M
Net Calls Change
+$63.6M
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$104M |
| 2 |
Sands Capital Management
Arlington,
Virginia
|
+$60.7M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$57.3M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$42.7M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$37M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$46.4M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$46.1M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$40.9M |
| 4 |
Renaissance Technologies
New York
|
-$37.9M |
| 5 |
AH
Aviva Holdings
New Providence,
Bahamas
|
-$35.4M |
